Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.61 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.61 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27834764 | 0.98 | PRSS1 (0.64) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL27476525 | 0.98 | PRSS1 (0.64) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL5158927 | 0.98 | PRSS1 (0.64) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL5164147 | 0.98 | PRSS1 (0.64) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL21879683 | 0.98 | PRSS1 (0.64) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| Adipic Acid SCHEMBL28248016 | 0.96 | PRSS1 (0.57) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL7569171 | 0.96 | PRSS1 (0.57) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL28234435 | 0.94 | PRSS1 (0.55) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL43233 | 0.94 | PRSS1 (0.67) | PRSS1PRSS2PRSS3KMT2AEGFR | |
| SCHEMBL25297232 | 0.92 | PRSS1 (0.70) | PRSS1PRSS2PRSS3KMT2AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020085686-A1 | POLYMERIZABLE COMPOSITION, AND COPOLYCARBONATE ESTER AND METHOD FOR PRODUCING SAME | 에스케이케미칼 주식회사 | 2020-04-30 | — | — | WO | disclosed |
| US-20170275389-A1 | NOVEL GLYCAN CONJUGATES AND USE THEREOF | ACADEMIA SINICA (TW) | 2017-09-28 | — | — | US | disclosed |
| US-20080193481-A1 | Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines | GOVERNORS OF THE UNIVERSITY OF ALBERTA | 2008-08-14 | — | — | US | disclosed |
| EP-1863536-A1 | SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES | The Governors of the University of Alberta (CA) | 2007-12-12 | — | — | EP | disclosed |
| WO-2006096970-A1 | SYNTHETIC ANTI-CANDIDA ALBICANS OLIGOSACCHARIDE BASED VACCINES | GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2006-09-21 | — | — | WO | disclosed |
| CN-1007818-B | IMPACT RESISTANT POLYMERIC COMPOSITIONS | SHELL INT RESEARCH (NL) | 1990-05-02 | — | — | CN | disclosed |
| CN-86105690-A | IMPACT RESISTANT POLYMERIC COMPOSITIONS | — | 1987-04-08 | — | — | CN | disclosed |
| US-4308269-A | ANTITUMOUR AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-12-29 | — | — | US | disclosed |
| EP-0021173-A1 | Maytansinoids, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1981-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193481-A1 | Synthetic Anti-Candida Albicans Oligosaccharide Based Vaccines | DDOST, FUT5, STT3B | PRSS1 1686/4885PRSS2 2523/4885PRSS3 1808/4885 |
| US-20170275389-A1 | NOVEL GLYCAN CONJUGATES AND USE THEREOF | STT3B, ST3GAL3, FUT6 | PRSS1 3523/4885PRSS2 3863/4885PRSS3 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.